uric acid has been researched along with tolvaptan in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Carluccio, AL; Merlin, MA; Zenenberg, RD | 1 |
| Czerwiec, FS; Glockner, J; Hogan, MC; Irazabal, MV; King, BF; Krasa, HB; Ofstie, TG; Ouyang, J; Torres, VE | 1 |
| Hirayama, A; Hori, M; Inomata, T; Izumi, T; Matsuzaki, M | 1 |
| Ambrosy, AP; Butler, J; Chioncel, O; Gheorghiade, M; Givertz, MM; Greene, SJ; Konstam, MA; Maggioni, AP; Mentz, RJ; Senni, M; Subacius, HP; Swedberg, K; Vaduganathan, M; Zannad, F | 1 |
| Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N | 1 |
| Cheungpasitporn, W; Enders, F; Erickson, SB; Lieske, JC; Rule, AD | 1 |
| Hada, T; Kawano, M; Muramatsu, T; Nakano, M; Nishio, S; Takimura, H; Takimura, Y; Tsukahara, R; Yabe, T | 1 |
| Decaux, G; Gankam Kengne, F | 1 |
| Chen, Q; Li, Y; Luo, H | 1 |
2 review(s) available for uric acid and tolvaptan
| Article | Year |
|---|---|
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance | 2010 |
Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Bicarbonates; Chronic Disease; Drinking; Humans; Hyponatremia; Practice Guidelines as Topic; Saline Solution; Saline Solution, Hypertonic; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Urea; Uric Acid | 2020 |
4 trial(s) available for uric acid and tolvaptan
| Article | Year |
|---|---|
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Contrast Media; Creatinine; Diuresis; Female; Glomerular Filtration Rate; Hormone Antagonists; Humans; Iothalamic Acid; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Minnesota; Organ Size; p-Aminohippuric Acid; Polycystic Kidney, Autosomal Dominant; Potassium; Receptors, Vasopressin; Renal Circulation; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid | 2011 |
Phase III clinical pharmacology study of tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Calcium; Creatinine; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema, Cardiac; Female; Furosemide; Humans; Magnesium; Male; Middle Aged; Potassium; Sodium; Tolvaptan; Uric Acid | 2011 |
Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diuretics; Drug Interactions; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Renal Insufficiency, Chronic; Tolvaptan; Uric Acid | 2015 |
Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.
Topics: Adolescent; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Calcium Oxalate; Calcium Phosphates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drinking; Female; Follow-Up Studies; Humans; Hyponatremia; Kidney Calculi; Male; Middle Aged; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid; Young Adult | 2016 |
3 other study(ies) available for uric acid and tolvaptan
| Article | Year |
|---|---|
Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
Topics: Age Factors; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Black or African American; Blood Pressure; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptides; Prognosis; Proportional Hazards Models; Renal Insufficiency; Risk Factors; Sex Factors; Stroke Volume; Systole; Tolvaptan; Treatment Outcome; Uric Acid; Ventricular Dysfunction, Left; White People | 2014 |
A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Diuretics; Female; Heart Failure; Heart Rate; Hematocrit; Hemoglobins; Hospitalization; Humans; Male; Risk Factors; Tolvaptan; Uric Acid | 2018 |
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric Acid | 2022 |